Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients

Journal of the National Cancer Institute

Volumn 88, Issue 24, 1996, Pages 1857-1863

  Tursz, Thomas ^a   Le Cesne, Axel ^a   Baldeyrou, Pierre ^a   Gautier, Eric ^a   Opolon, Paule ^a   Schatz, Christian ^b   Pavirani, Andrea ^b   Courtney, Michael ^b   Lamy, Didier ^b   Ragot, Thierry ^a   Saulnier, Patrick ^a   Andremont, Antoine ^a   Monier, Roger ^a   Perricaudet, Michel ^a   Le Chevalier, Thierry ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b TRANSGENE S A   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ARTICLE; BRONCHOSCOPY; CLINICAL TRIAL; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG CANCER; MARKER GENE; PHASE 1 CLINICAL TRIAL; PLAQUE FORMING CELL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; VIRUS RECOMBINATION; VIRUS TRANSCRIPTION;

ADENOVIRIDAE; BETA-GALACTOSIDASE; BRONCHIAL NEOPLASMS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CARCINOMA; FEASIBILITY STUDIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 12644271889     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.24.1857     Document Type: Article

References (30)

1. Minna JD, Pass H. Glatstein E, et al. Cancer of the lung. In: DeVita VT Jr, Hellman S, Rosenberg SA. editors. Cancer: principles and practice of oncology. 3rd ed. Philadelphia: Lippincott, 1989:591-705.
2. Ihde DC. Drug therapy: chemotherapy of lung cancer. N Engl J Med 1992;327:1434-41.
3. Arriagada R, Kramar A, Le Chevalier T, De Cremoux H. Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Centers' Lung Group. J Clin Oncol 1992;10:447-51.
4. Carbone DP, Minna JD. The molecular genetics of lung cancer. Adv Intern Med 1992; 37:153-71.
5. Sugio K, Ishida T, Yokoyama H, Inoue T, Sugimachi K, Sasazuki T. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung with lymph node metastasis. Cancer Res 1992;52:2903-6.
6. Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, et al. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res 1993;53:1-4.
7. Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res 1991;51:1744-8.
8. Fujiwara T, Cai DW, Georges RN, Mukhopadhyay T, Grimm EA, Roth JA. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model [see comment citation in Medline]. J Natl Cancer Inst 1994;86:1458-62.
9. Carbone DP, Minna JD. In vivo gene therapy of human lung cancer using wild-type p53 delivered by retrovirus [editorial] [see comment citation in Medline]. J Natl Cancer Inst 1994;86:1437-8.
10. Stratford-Perricaudet L, Perricaudet M. Gene transfer into animals; the promise of adenovirus. In: Cohen-Haguenauer O, Borion M, editors. Human gene transfer. Vol 219. Montrouge. France: John Libbey Eurotext, 1991:51-61.
11. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995;69:2004-15.
12. O'Malley BW Jr, Chen SH, Schwartz MR, Woo SL. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 1995;55:1080-5.
13. Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 1995;55:1-6.
14. Smythe WR, Kaiser LR, Hwang HC, Amin KM, Pikewski JM, Eck SJ, et al. Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma [see comment citation in Medline]. Ann Thorac Surg 1994;57:1395-401.
15. Cordier L, Duffour MT, Sabourin JC, Lee MG, Cabannes J, Ragot T, et al. Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Gene Ther 1995;2:16-21.
16. Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients [see comment citation in Medline]. J Clin Oncol 1994;12:360-7.
17. Ihde DC, Mulshine JL, Kramer BS, Steinberg SM, Linnoila RI. Gazdar AF, et al. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 1994;12:2022-34.
18. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992;90:626-30.
19. Bonnerot C, Rocancourt D, Briand P, Grimber G, Nicolas JF. A beta-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc Natl Acad Sci USA 1987;84:6795-9.
20. Lenett DA. Collection and preparation of specimens for virological examination. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 6th ed. Washington (DC): American Society for Microbiology, 1995: 868-75.
21. Rogers MF, Ou CY, Rayfield M, Thomas PA, Schoenbaum EE, Abrams E, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med 1989;320:1649-54.
22. Khan G, Kangro HO, Coates PJ, Heath RB. Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA. J Clin Pathol 1991;44:360-5.
23. McDonough M, et al. PCR detection of human adenovirus. In: Pershing DH, Smith TH, Tenover FC, White TJ, editors. Diagnostic molecular microbiology. Washington (DC): American Society for Microbiology, 1993: 389-93.
24. Hierholzer JC. Adenovirus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 6th ed. Washington (DC): American Society for Microbiology, 1995:947-55.
25. Voller A, Bidwell DE, Bartlett A. The enzyme linked immunosorbent assay (ELISA). A guide with abstracts of microplate applications. Guernsey (UK): Dynatech Europe, Burough House, 1979.
26. World Health Organization. WHO handbook for reporting the results of cancer treatment. Vol 48. Geneva: WHO Offset Publication, 1979.
27. Prakash U, Freitag L. Hemoptysis and bronchoscopy-induced hemorrage. In: Prakash UB, editor. Bronchoscopy. New York. Mayo Foundation, Raven Press Ltd, 1994:227-51.
28. Watanabe A. Fever and bacteremia following flexible bronchoscopy. J Bronchol 1994;1:5-8.
29. Crystal RG, McElvaney NG, Rosenfeld MA, Chu CS, Mastrangeli A, Hay JG, et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis [see comment citation in Medline]. Nat Genet 1994;8:42-51.
30. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(4 Suppl): 225S-233S.